Exocrine Pancreatic Insufficiency Therapeutics Market Analysis, Share, Size, Industry Trends

The global exocrine pancreatic insufficiency therapeutics market to reach USD 2.55 billion by 2026, exhibiting a CAGR of 6.5% during the forecast period. Increasing prevalence of diabetes worldwide is touted to be one of the core factors fueling the growth of this market. According to the International Diabetes Federation (IDF), in 2019, approximately 463 million adults were suffering from diabetes and by 2045, this figure will rise to 700 million. In the same year, the disease caused deaths of 4.2 million people and around 374 million people are at an increased risk of developing type 2 diabetes.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/exocrine-pancreatic-insufficiency-market-100652

Table of Content from Exocrine Pancreatic Insufficiency Therapeutics Market:

1. Introduction

1.1. Research Scope

1.2. Market Segmentation

1.3. Research Methodology

1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

4. Key Insights

4.1. Prevalence of Major Disorders Associated With Exocrine Pancreatic Insufficiency

4.2. Pipeline Analysis

4.3. Recent Industry Developments Such as Mergers, Partnerships & Acquisitions

4.4. Regulatory Scenario

4.5. New Product Launches

5. Global Exocrine Pancreatic Insufficiency Therapeutics Market Analysis, Insights and Forecast, 2015-2026

5.1. Key Findings / Summary

5.2. Market Analysis, Insights and Forecast – By Therapy

5.2.1. Pancreatic Enzyme Replacement Therapy (PERT)

5.2.1.1. Creon

5.2.1.2. Zenpep

5.2.1.3. Others

5.2.2. Nutritional Therapy

5.3. Market Analysis, Insights and Forecast – By Distribution Channel

5.3.1. Hospital Pharmacies

5.3.2. Retail Pharmacies & Drug Stores

5.3.3. Others

5.4. Market Analysis, Insights and Forecast – By Country

5.4.1. North America

5.4.2. Europe

5.4.3. Asia Pacific

5.4.4. Rest of the World

6. North America Exocrine Pancreatic Insufficiency Therapeutics Market Analysis, Insights and Forecast, 2015-2026

6.1. Key Findings / Summary

6.2. Market Analysis – By Therapy

6.2.1. Pancreatic Enzyme Replacement Therapy (PERT)

6.2.1.1. Creon

6.2.1.2. Zenpep

6.2.1.3. Others

6.2.2. Nutritional Therapy

6.3. Market Analysis – By Distribution Channel

6.3.1. Hospital Pharmacies

6.3.2. Retail Pharmacies & Drug Stores

6.3.3. Others

6.4. Market Analysis – By Country

6.4.1. U.S.

6.4.2. Canada

TOC Continued…..